$20.37
1.699.05%
At close: -
$20.50
0.130.64%
After Hours: Apr 17, 4:48 PM EDT
Comments
Loading...
Biohaven Analyst Ratings and Price Targets | NYSE:BHVN | Benzinga
Biohaven Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Biohaven Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
JP Morgan
HC Wainwright & Co.
RBC Capital
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for Biohaven
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/07/2025 | Buy Now | — | Morgan Stanley | Terence Flynn65% | $69 → $63 | Maintains | Overweight | Get Alert |
| 03/05/2025 | Buy Now | — | JP Morgan | Tessa Romero57% | $72 → $68 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $54 → $54 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2025 | Buy Now | — | RBC Capital | Leonid Timashev35% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 02/11/2025 | Buy Now | — | Deutsche Bank | David Hoang35% | → $65 | Initiates | → Buy | Get Alert |
| 12/17/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | Overweight → Overweight | Get Alert |
| 12/17/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $58 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 11/26/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $66 → $58 | Maintains | Outperform | Get Alert |
| 11/14/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | — | TD Cowen | Tyler Van Buren45% | $55 → $75 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $68 → $66 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 10/04/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 10/03/2024 | Buy Now | — | JP Morgan | Tessa Romero57% | $55 → $68 | Maintains | Overweight | Get Alert |
| 09/24/2024 | Buy Now | — | Bernstein | William Pickering39% | $55 → $66 | Maintains | Outperform | Get Alert |
| 09/24/2024 | Buy Now | — | B of A Securities | Jason Gerberry61% | $52 → $62 | Maintains | Buy | Get Alert |
| 09/24/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $59 → $68 | Maintains | Outperform | Get Alert |
| 09/24/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 09/24/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 09/23/2024 | Buy Now | — | Leerink Partners | Marc Goodman73% | $55 → $60 | Maintains | Outperform | Get Alert |
| 09/23/2024 | Buy Now | — | Piper Sandler | Christopher Raymond55% | $66 → $76 | Maintains | Overweight | Get Alert |
| 09/23/2024 | Buy Now | — | Baird | Brian Skorney57% | $58 → $60 | Maintains | Outperform | Get Alert |
| 09/16/2024 | Buy Now | — | Jefferies | Amy Li3% | → $57 | Initiates | → Buy | Get Alert |
| 09/04/2024 | Buy Now | — | Bernstein | William Pickering39% | → $55 | Initiates | → Outperform | Get Alert |
| 09/04/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
| 08/19/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 08/13/2024 | Buy Now | — | UBS | Ashwani Verma40% | $55 → $54 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 07/24/2024 | Buy Now | — | Morgan Stanley | Terence Flynn65% | → $58 | Initiates | → Overweight | Get Alert |
| 06/18/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $59 → $59 | Reiterates | Outperform → Outperform | Get Alert |
| 05/30/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $59 → $59 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 05/13/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $63 → $59 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | — | UBS | Ashwani Verma40% | $59 → $60 | Maintains | Buy | Get Alert |
| 04/18/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | — | Reiterates | → Overweight | Get Alert |
| 04/09/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $61 → $61 | Reiterates | Outperform → Outperform | Get Alert |
| 03/04/2024 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | $50 → $63 | Maintains | Buy | Get Alert |
| 03/01/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | $62 → $61 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | — | TD Cowen | Tyler Van Buren45% | $35 → $55 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | — | JP Morgan | Tessa Romero57% | $32 → $56 | Maintains | Overweight | Get Alert |
| 02/16/2024 | Buy Now | — | RBC Capital | Leonid Timashev35% | → $62 | Initiates | → Outperform | Get Alert |
| 02/06/2024 | Buy Now | — | UBS | Ashwani Verma40% | → $59 | Initiates | → Buy | Get Alert |
| 12/22/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | → $50 | Initiates | → Buy | Get Alert |
| 12/08/2023 | Buy Now | — | Baird | Brian Skorney57% | → $58 | Initiates | → Outperform | Get Alert |
| 11/20/2023 | Buy Now | — | JP Morgan | Tessa Romero57% | $26 → $32 | Maintains | Overweight | Get Alert |
| 11/15/2023 | Buy Now | — | Piper Sandler | Christopher Raymond55% | $29 → $36 | Maintains | Overweight | Get Alert |
| 08/16/2023 | Buy Now | — | JP Morgan | Tessa Romero57% | $27 → $24 | Maintains | Overweight | Get Alert |
| 07/17/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | → $31 | Reiterates | Overweight → Overweight | Get Alert |
| 06/06/2023 | Buy Now | — | BTIG | Thomas Shrader40% | $24 → $24 | Reiterates | → Buy | Get Alert |
| 04/04/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan68% | $27 → $31 | Maintains | Overweight | Get Alert |
| 01/24/2023 | Buy Now | — | SVB Leerink | Marc Goodman73% | → $24 | Initiates | → Outperform | Get Alert |
| 01/04/2023 | Buy Now | — | JP Morgan | Tessa Romero57% | → $23 | Initiates | → Overweight | Get Alert |
| 12/02/2022 | Buy Now | — | BTIG | Thomas Shrader40% | → $24 | Initiates | → Buy | Get Alert |
| 10/26/2022 | Buy Now | — | Piper Sandler | Christopher Raymond55% | $23 → $21 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | — | Piper Sandler | Christopher Raymond55% | → $23 | Initiates | → Overweight | Get Alert |
| 08/19/2022 | Buy Now | — | Piper Sandler | Christopher Raymond55% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/08/2022 | Buy Now | — | Wedbush | Laura Chico44% | → $148.5 | Downgrade | Outperform → Neutral | Get Alert |
| 05/11/2022 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao50% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/11/2022 | Buy Now | — | Morgan Stanley | Jeffrey Hung50% | $146 → $148.5 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | — | SVB Leerink | Marc Goodman73% | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Biohaven (BHVN) stock?
The latest price target for Biohaven (NYSE:BHVN) was reported by Morgan Stanley on March 7, 2025. The analyst firm set a price target for $63.00 expecting BHVN to rise to within 12 months (a possible 207.32% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biohaven (BHVN)?
The latest analyst rating for Biohaven (NYSE:BHVN) was provided by Morgan Stanley, and Biohaven maintained their overweight rating.
When was the last upgrade for Biohaven (BHVN)?
There is no last upgrade for Biohaven
When was the last downgrade for Biohaven (BHVN)?
The last downgrade for Biohaven Ltd happened on August 19, 2022 when Piper Sandler changed their price target from N/A to N/A for Biohaven Ltd.
When is the next analyst rating going to be posted or updated for Biohaven (BHVN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biohaven, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biohaven was filed on March 7, 2025 so you should expect the next rating to be made available sometime around March 7, 2026.
Is the Analyst Rating Biohaven (BHVN) correct?
While ratings are subjective and will change, the latest Biohaven (BHVN) rating was a maintained with a price target of $69.00 to $63.00. The current price Biohaven (BHVN) is trading at is $20.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
